Literature DB >> 1082919

The requirement for two complementing Ir-GLphi immune response genes in the T-lymphocyte proliferative response to poly-(Glu53Lys36Phe11).

R H Schwartz, M E Dorf, B Benacerraf, W E Paul.   

Abstract

The antibody response to poly-(Glu53Lys36Phe11) (GLphi) has been shown to be under the control of two independent, major histocompatibility-linked immune response genes, designated alpha and beta. In the present work we demonstrate that the T-lymphocyte proliferative response is also under the control of these two immune response genes. Thus, mice of the H-2a, H-2b, H-2k, and H-2s haplotypes were all nonresponders to GLphi. In contrast F1 hybrids between these strains, such as (B10 X B10.A)F1 and (C3H X SJL)F1, as well as several recombinant mice derived from the nonresponder haplotypes, such as B10.1(5R), B10.HTT, and B10.S(9R), were all responders to GLphi. The complementation between nonresponder genomes appeared to be stronger in the cis position than in the trans position for some strain combinations. The failure of strains bearing only one of the two responder alleles to show a T-lymphocyte proliferative response to GLphi, argues strongly that neither gene can be expressed exclusively in B lymphocytes. This conclusion is discussed in relation to another two gene model which has recently been proposed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082919      PMCID: PMC2190158          DOI: 10.1084/jem.143.4.897

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Control of t-lymphocyte and B-lymphocyte activation by two complementing Ir-GLphi immune response genes.

Authors:  D H Katz; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

2.  Complementation of H-2-linked Ir genes in the mouse.

Authors:  M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  Mechanisms of action of genes controlling the immune response.

Authors:  E Shevach; S Z Ben-Sasson; F Finkelman; W E Paul; I Green
Journal:  Transplant Proc       Date:  1975-06       Impact factor: 1.066

4.  Two genes in the major histocompatibility complex control immune response.

Authors:  A J Munro; M J Taussig
Journal:  Nature       Date:  1975-07-10       Impact factor: 49.962

5.  T lymphocyte-enriched murine peritoneal exudate cells. I. A reliable assay for antigen-induced T lymphocyte proliferation.

Authors:  R H Schwartz; L Jackson; W E Paul
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

6.  Genetic control of the immune response: in vitro stimulation of lymphocytes by (T,G)-A--L, (H,G)-A--L, and (Phe,G)-A--L.

Authors:  P Lonai; H O McDevitt
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

7.  Inclusion group systems and cis-trans effects in responses controlled by the two complementing Ir-GLphi genes.

Authors:  M E Dorf; P H Maurer; F Merryman; B Benacerraf
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

8.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. II. Role of the macrophage in the regulation of genetic control of the immune response.

Authors:  E M Shevach; A S Rosenthal
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

  8 in total
  22 in total

1.  Control of t-lymphocyte and B-lymphocyte activation by two complementing Ir-GLphi immune response genes.

Authors:  D H Katz; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

2.  T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes.

Authors:  A M Solinger; M E Ultee; E Margoliash; R H Schwartz
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

3.  Inhibition of dual Ir gene-controlled T-lymphocyte proliferative response to poly (Glu56Lys35Phe9)n with anti-Ia antisera directed against products of either I-A or I-C subregion.

Authors:  R H Schwartz; C S David; M E Dorf; B Benacerraf; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

4.  Hybrid (combinatorial) Ia specificities: gene complementations to generate Ia.22.

Authors:  W P Lafuse; J F McCormick; P S Corser; C S David
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Complementation between a gene of the I-E subregion and a non-H-2 gene in the class-specific suppression of IgG2a antibody to sheep erythrocytes.

Authors:  M Seman; V Zilberfarb
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Characterization of three new intra-I region recombinant mouse strains, B10.ASR7 (H-2as3), B10.BAR4 (H-2h6), and B10.BASR1 (H-2as4).

Authors:  P M Allen; D H Gutmann; M R Sher; J E Niederhuber
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  Genetic control of T-cell proliferative responses to poly(glu40ala60) and poly(glu51lys34tyr15): subregion-specific inhibition of the responses with monoclonal Ia antibodies.

Authors:  C N Baxevanis; D Wernet; Z A Nagy; P H Maurer; J Klein
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

8.  Cell-mediated lympholysis to H-2-matched target cells modified with a series of nitrophenyl compounds.

Authors:  T G Rehn; J K Inman; G M Shearer
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

9.  Regulation of immune responses by I-J gene products. II. Presence of Both I-Jb and I-Jk suppressor factors in (nonsuppressor x nonsuppressor) F1 mice.

Authors:  H Y Lei; M E Dorf; C Waltenbaugh
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  IR gene regulation of the response to trinitrophenyl-polysaccharides. Two independent genes are required for antibody production.

Authors:  L M Hillstrom; J E Niederhuber
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.